M

Mineralys Therapeutics Inc
NASDAQ:MLYS

Watchlist Manager
Mineralys Therapeutics Inc
NASDAQ:MLYS
Watchlist
Price: 36.83 USD -0.83% Market Closed
Market Cap: 2.9B USD

Wall Street
Price Targets

MLYS Price Targets Summary
Mineralys Therapeutics Inc

Wall Street analysts forecast MLYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLYS is 50.62 USD with a low forecast of 42.42 USD and a high forecast of 58.8 USD.

Lowest
Price Target
42.42 USD
15% Upside
Average
Price Target
50.62 USD
37% Upside
Highest
Price Target
58.8 USD
60% Upside
Mineralys Therapeutics Inc Competitors:
Price Targets
6160
Beigene Ltd
38% Upside
CMPX
Compass Therapeutics Inc.
144% Upside
MDXH
MDxHealth SA
114% Upside
300685
Amoy Diagnostics Co Ltd
44% Upside
TNG
Transgene SA
60% Upside
QURE
Uniqure NV
121% Upside
EXAS
Exact Sciences Corp
1% Downside
RARE
Ultragenyx Pharmaceutical Inc
325% Upside

Revenue
Forecast

Revenue Estimate
Mineralys Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mineralys Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Mineralys Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLYS's stock price target?
Price Target
50.62 USD

According to Wall Street analysts, the average 1-year price target for MLYS is 50.62 USD with a low forecast of 42.42 USD and a high forecast of 58.8 USD.

Back to Top